Your "Free" Colonoscopy and the Bill That Follows: Screening vs. Diagnostic, Decoded

It's the most famous version of the preventive-visit switcheroo: you do the responsible thing, the gastroenterologist finds and removes a small polyp (which is the screening working), and weeks later a four-figure bill arrives because the procedure was recoded from screening to diagnostic. NPR built a whole story around a $2,185 example. The rules have since been rewritten in patients' favor, in stages, and knowing which stage applies to your insurance is the whole fight.

The vocabulary that decides the bill

• Screening (preventive): ordered on schedule (currently starting at age 45 for average risk) with no symptoms. ACA plans and Medicare cover it at $0.
• Diagnostic: ordered because of symptoms (bleeding, pain, anemia, changes) or to investigate a known problem. Normal deductibles and coinsurance apply from the start, honestly.
• Surveillance: the repeat colonoscopy on a shortened interval because previous ones found polyps. Commercial plans mostly treat these as preventive under the guidance; Medicare treats them as screenings on its allowed frequencies. This is the murkiest category, and worth a pre-procedure coverage question.
• The trap: a screening that finds something and gets rebilled as diagnostic after the fact. This is the part the rules now mostly forbid.

Commercial insurance: the 2022 rules most billers know and some ignore

Two federal clarifications govern ACA-compliant plans. First, polyp removal during a screening colonoscopy is an integral part of the screening: the procedure stays preventive, $0 cost sharing, pathology included (the American Cancer Society summarizes the coverage law). Second, since plan years starting mid-2022, a follow-up colonoscopy after a positive non-invasive screening test (Cologuard, FIT, and similar) must be covered as preventive, without cost sharing, because the screening isn't complete until the colonoscopy is done. If you get billed in either situation, the magic words are: "This was a screening under the ACA preventive services requirement and the 2022 federal guidance; please review the coding." Route it to the provider's biller AND the plan, and appeal the rare one that survives the phone call.

Medicare: better than it was, on a schedule

1. The screening itself: $0, no deductible, at Medicare's allowed frequencies (every 10 years average-risk, more often for high-risk).
2. Polyps found and removed: the procedure converts to diagnostic under Medicare's rules, but the CAA phase-down caps your share: 15% coinsurance through 2026, 10% in 2027-2029, 0% from 2030, with the Part B deductible waived throughout. A bill for more than the phase-down percentage is miscoded.
3. After a positive Cologuard or FIT: free since January 2023. Medicare now defines the follow-up colonoscopy as completing the screening; the biller's KX modifier makes it process correctly, and its absence is the usual cause of wrong bills.
4. Watch the [anesthesia and facility lines](/blog/how-to-read-an-eob): the same preventive status should flow to the anesthesia and facility claims for a screening; mismatches there are the second most common error.

If the bill already arrived

Run the standard machine with the colonoscopy-specific vocabulary: get the itemized bill and match the EOB, identify which claim (physician, facility, anesthesia, pathology) processed as diagnostic, call the biller with the scheduled-as-screening framing and the applicable rule (2022 guidance for commercial, the phase-down or the 2023 follow-up rule for Medicare), and escalate unresolved ones as a coding appeal. These disputes have unusually high win rates because the rules are written down and recent; persistence is usually one call and one letter.